Myeloid-derived growth factor alleviates non-alcoholic fatty liver disease alleviates in a manner involving IKKβ/NF-κB signaling
Yan Ding(Hubei University of Medicine), Guangda Xiang(Central Hospital of Wuhan)
Cited by 27
Related Papers
RETRACTED ARTICLE: Myeloid‐derived growth factor (MYDGF) protects bone mass through inhibiting osteoclastogenesis and promoting osteoblast differentiation
|EMBO Reports|2022|20
Sweroside alleviates hepatic steatosis in part by activating AMPK/mTOR‐mediated autophagy in mice
|Journal of Cellular Biochemistry|2023|14
Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice
|Journal of Cellular Biochemistry|2023|6
Sweroside Inhibits Inflammation and Alleviates Endothelial Injury and Atherosclerosis in Mice
|Journal of Cellular and Molecular Medicine|2025|1